(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 4.69% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.04%.
Sotera Health Co's revenue in 2024 is $1,076,874,000.On average, 3 Wall Street analysts forecast SHC's revenue for 2024 to be $310,975,948,027, with the lowest SHC revenue forecast at $309,141,649,075, and the highest SHC revenue forecast at $312,793,262,730. On average, 3 Wall Street analysts forecast SHC's revenue for 2025 to be $332,609,918,975, with the lowest SHC revenue forecast at $328,871,685,647, and the highest SHC revenue forecast at $336,902,404,980.
In 2026, SHC is forecast to generate $360,196,303,252 in revenue, with the lowest revenue forecast at $360,196,303,252 and the highest revenue forecast at $360,196,303,252.